JP2024509907A5 - - Google Patents

Info

Publication number
JP2024509907A5
JP2024509907A5 JP2023555193A JP2023555193A JP2024509907A5 JP 2024509907 A5 JP2024509907 A5 JP 2024509907A5 JP 2023555193 A JP2023555193 A JP 2023555193A JP 2023555193 A JP2023555193 A JP 2023555193A JP 2024509907 A5 JP2024509907 A5 JP 2024509907A5
Authority
JP
Japan
Application number
JP2023555193A
Other languages
Japanese (ja)
Other versions
JPWO2022190100A5 (https=
JP2024509907A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IL2022/050269 external-priority patent/WO2022190100A1/en
Publication of JP2024509907A publication Critical patent/JP2024509907A/ja
Publication of JP2024509907A5 publication Critical patent/JP2024509907A5/ja
Publication of JPWO2022190100A5 publication Critical patent/JPWO2022190100A5/ja
Pending legal-status Critical Current

Links

JP2023555193A 2021-03-10 2022-03-09 レボドパ-チロシンコンジュゲートを含む安定した液体組成物およびそれらの使用 Pending JP2024509907A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202163159236P 2021-03-10 2021-03-10
US63/159,236 2021-03-10
US202263296032P 2022-01-03 2022-01-03
US63/296,032 2022-01-03
PCT/IL2022/050269 WO2022190100A1 (en) 2021-03-10 2022-03-09 Stabilized liquid compositions comprising a levodopa-tyrosine conjugate and uses thereof

Publications (3)

Publication Number Publication Date
JP2024509907A JP2024509907A (ja) 2024-03-05
JP2024509907A5 true JP2024509907A5 (https=) 2025-03-18
JPWO2022190100A5 JPWO2022190100A5 (https=) 2025-03-18

Family

ID=83226570

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023555193A Pending JP2024509907A (ja) 2021-03-10 2022-03-09 レボドパ-チロシンコンジュゲートを含む安定した液体組成物およびそれらの使用

Country Status (11)

Country Link
US (1) US20240207410A1 (https=)
EP (1) EP4305049A4 (https=)
JP (1) JP2024509907A (https=)
KR (1) KR20230155508A (https=)
AU (1) AU2022232759A1 (https=)
BR (1) BR112023018202A2 (https=)
CA (1) CA3211324A1 (https=)
IL (1) IL305717A (https=)
MX (1) MX2023010450A (https=)
TW (1) TW202302621A (https=)
WO (1) WO2022190100A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4460289A4 (en) * 2022-01-03 2025-09-03 Neuroderm Ltd METHODS AND COMPOSITIONS FOR THE TREATMENT OF PARKINSON'S DISEASE
CN116850159B (zh) * 2023-07-12 2025-08-22 浙江同伍生物医药有限公司 一种盐酸左沙丁胺醇雾化吸入溶液组合物及其制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4035507A (en) * 1975-04-17 1977-07-12 Interx Research Corporation Novel, transient pro-drug forms of L-DOPA to treat Parkinson's disease
DE69016688T2 (de) * 1989-04-20 1995-10-05 Zambon Spa Dopamin-Medikament-Vorstufe.
WO2009101616A1 (en) * 2008-02-11 2009-08-20 Ramot At Tel Aviv University Ltd. Novel conjugates for treating neurodegenerative diseases and disorders
EP2640358B1 (en) * 2010-11-15 2018-01-03 Neuroderm Ltd Continuous administration of l-dopa, dopa decarboxylase inhibitors, catechol-o-methyl transferase inhibitors and compositions for same
RU2743347C2 (ru) * 2014-10-21 2021-02-17 Эббви Инк. Пролекарства карбидопа и l-dopa и их применение для лечения болезни паркинсона
WO2018154447A1 (en) * 2017-02-21 2018-08-30 Neuroderm Ltd Dopa decarboxylase inhibitor compositions
CN110294789A (zh) * 2018-03-21 2019-10-01 海南大学 含多巴寡肽的合成方法及其在抗帕金森病前药方面的应用
US20210380525A1 (en) * 2018-10-08 2021-12-09 Cellix Bio Provate Limited Compositions and methods for the treatment of parkinson's disease
WO2020178810A1 (en) * 2019-03-04 2020-09-10 Neuroderm, Ltd. Pharmaceutical compositions comprising levodopa amide derivatives and uses thereof
US20220362386A1 (en) * 2019-09-05 2022-11-17 Neuroderm, Ltd. Liquid compositions comprising a levodopa amino acid conjugate and uses thereof

Similar Documents

Publication Publication Date Title
JP2024509907A5 (https=)
BR102022025291A2 (https=)
CL2025003966A1 (es) Lazo de inducción para exploración minera
BR102023014872A2 (https=)
BR102023012440A2 (https=)
BR102023010976A2 (https=)
BR102023009641A2 (https=)
BR102023008688A2 (https=)
BR102023007252A2 (https=)
BR102023005164A2 (https=)
BR102023001877A2 (https=)
BR102023000289A2 (https=)
BR102022026909A2 (https=)
BR202022009269U2 (https=)
BR202022005961U2 (https=)
BR202022001779U2 (https=)
BR202022000931U2 (https=)
BY13149U (https=)
BY13160U (https=)
BY13141U (https=)
BY13142U (https=)
BY13143U (https=)
BY13144U (https=)
BY13145U (https=)
BY13176U (https=)